CLINICAL_TRIALS
trial_result
· 2023-12-26
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease [Phase 2]
Summary
A Phase 2 study evaluating AZD5718 in proteinuric chronic kidney disease was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-12-26